FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based TechnologyGlobeNewsWire • 09/12/24
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 09/06/24
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyGlobeNewsWire • 08/20/24
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyGlobeNewsWire • 06/25/24
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeGlobeNewsWire • 04/11/24
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USAGlobeNewsWire • 04/04/24
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusGlobeNewsWire • 03/28/24
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentPRNewsWire • 03/19/24
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumPRNewsWire • 02/20/24
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory DiseasesPRNewsWire • 02/13/24
U.S. IPO Weekly Recap: Amer Sports' Billion-Dollar U.S. IPO Leads A Week Of Large ListingsSeeking Alpha • 02/04/24